255 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
15 Dec 08
Discovery Labs Secures $25 Million Committed Equity Financing Facility
12:00am
CEFF also provides us with flexibility to manage Discovery Labs’ financial position during the difficult economic environment that currently plagues … limitations; changes in the national or international political and regulatory environment may make it more difficult for Discovery Labs to gain FDA
FWP
WINT
Windtree Therapeutics Inc
7 Dec 07
Free writing prospectus
12:00am
factors, such as the progress of our research and development efforts, technological advances and the competitive environment for Surfaxin and our other
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
12 Nov 02
Other events
12:00am
financing environment for the biotechnology industry, investor interest exceeded
the $13 million limit established by our Board of Directors
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
26 Feb 10
Discovery Labs Announces Completion of
12:00am
) changes in the national or international political and regulatory environment may make it more difficult to gain FDA or other regulatory approval; risks
8-K
EX-99.1
8c49id3h4fs9g90 rh96
18 Feb 10
Discovery Labs Prices $16.5 Million Public Offering of
12:00am
8-K
EX-99.1
w9wkqrxgc 0h7mma
2 May 08
Discovery Labs Receives an Approvable Letter from FDA
12:00am
8-K
EX-99.1
lr7gpuekuswjwzrb
8 May 09
Discovery Labs to Raise $11.3 Million in Registered Direct Offering
12:00am
8-K
EX-99.1
5klo0 skooki8
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
cqp3mt
26 Feb 10
Discovery Labs Announces Completion of
12:00am
8-K
EX-99.1
15z1y5qzmm4jk3
5 Oct 01
Other events
12:00am
8-K
EX-99.1
yqj1yq3fh55ocxaau kc
29 May 08
Other Events
12:00am
8-K
EX-99.1
4z0508c6
31 Jan 24
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
8:00am
8-K
vres wau4onsdttwmqnh
8 May 09
Discovery Labs to Raise $11.3 Million in Registered Direct Offering
12:00am
8-K
EX-99.1
eeoymhcl903sdjwu5pfv
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
8-K
EX-99.2
e483u0ixa53gq5pvm
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
8-K
EX-99.1
31ffduxdugia uvdjgux
14 Jun 10
Discovery Labs Secures $35 Million Committed Equity Financing Facility
12:00am
8-K
EX-99.2
wyvr95 nk
10 Nov 08
Discovery Labs Reports Third Quarter 2008 Financial Results
12:00am
8-K
EX-99.1
0b7sgfr2wsez7n2m92
5 Dec 22
Other Events
7:48am